Last reviewed · How we verify
Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1
rabies mab CBB 1 is mainly used for passive immunization of patients bitten or scratched by rabies or other animals carrying rabies virus, this study mainly studies the safety, tolerability, pharmacokinetics, neutralizing antibody activity and immunogenic characteristics of rabies mAb CBB 1 in healthy adults
Details
| Lead sponsor | Changchun BCHT Biotechnology Co. |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | UNKNOWN |
| Enrolment | 152 |
| Start date | Sun Apr 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Rabies Virus Infection
Interventions
- Natural full human monoclonal antibody CBB 1 injection
- Rabies Human Immunoglobulin (HRIG)
- Natural full human monoclonal antibody CBB 1 injection placebo
- Lyophilized rabies vaccine for human use (Vero cells)
Countries
China